Latest Cash Flow Management News

Health and Plant Protein Group Limited reported a decline in cash reserves to $0.90 million for Q2 FY25, continuing its efforts to resolve a US tax withholding issue tied to a previous asset sale.

Dreadnought Resources reported a challenging quarter with significant exploration spending and a tight cash position, yet remains confident in its operational outlook and funding prospects.

Carly Holdings Limited has reported a 41% jump in customer receipts and its highest-ever subscription revenue in the December 2024 quarter, alongside significant cost reductions and strategic fleet adjustments.

Nutritional Growth Solutions reported a slight revenue decline in Q4 FY24 but remains optimistic about growth and profitability in FY25, buoyed by renewed Walmart partnerships and expanding Asian distribution.

Epsilon Healthcare Limited reported a modest cash increase in its December quarter but remains under administration with no unused financing facilities, raising questions about its operational future.

Electro Optic Systems (EOS) has completed the divestment of its EM Solutions subsidiary for $158.6 million, wiping out all borrowings and positioning itself with a strong cash balance of approximately $128 million. The company is actively pursuing significant defence contracts and expanding its manufacturing footprint.

Anagenics Limited reports a marked reduction in cash outflows and operating costs following a strategic restructuring, with full benefits expected in the latter half of FY2025. Despite divesting Face Medi, core cosmetics sales remain steady.

8common Limited reports a record $1.2 million in SaaS revenue for Q2 FY25, driven by a 12% increase in users and strong government contract activity. Despite tight cash balances, the company remains funded through a chairman-backed facility.

Ark Mines Ltd reported a significant cash outflow in its December 2024 quarter, prompting plans for a capital raising to support ongoing exploration activities.

Visioneering Technologies reported a mixed Q4 FY'24 with a slight revenue decline but stronger cash flow and expanding global footprint, underpinned by promising clinical trial data.

IODM Limited reported a decline in cash reserves to $461,000 for the December quarter, while projecting revenue growth through new university client onboarding in the UK and North America.

Mastermyne Group Limited reported a 14% rise in EBITDA to $4.1 million for FY25 Q2, even as revenue fell 10% due to operational disruptions at Anglo American’s Grosvenor mine. The company secured key contract extensions and maintained a strong cash position, positioning itself for growth amid sector uncertainties.